Our MBC Life SHARE Cancer Support

In this second of three episodes on managing bone metastases in MBC, we bring you a broad review of the major interventions to treat and manage bone mets. We explain the differences among the specialties of Radiology (think x-rays and PET/CT scans) vs. Radiation Oncology (external beam, Stereotactic Radiation Surgery (SRS) or Stereotactic Body Radiation Therapy (SBRT) and Interventional Radiology (Biopsies, Cryoablation, Radiofrequency Ablation among others). The majority of patients with MBC...

Today’s episode is the first in a three part series covering all things related to bone metastasis. In our first episode, we’re covering the basics starting with some bone education. We’re joined by Dr. Azeez Farooki, an endocrinologist at MSK, who discusses his role on treatment for bone disease stemming from breast cancer. We’re also joined by Dr. Monica Fornier, a breast medical oncologist also at MSK, who treats people living with metastatic breast cancer. Both doctors will be diving into...

Even though breast cancer research is comparatively well-funded, researchers still don't fully understand the many different ways metastatic cancer eventually evades currently available treatments. Just like a detective can learn much from studying the scene of a crime, researchers need to understand how breast cancer causes death to better understand how to stop it from doing so. One of the quickest ways for them to do that is through something called a tissue donation program.Ma...

Did you know that in the US rural communities have lower cancer rates but higher death rates from cancer? Did you know that only 3% of medical oncologists practice in rural communities?When it comes to cancer, living in a rural area puts people at a disadvantage.They face limited access to quality healthcare, long travel times, and low recruitment to clinical trials, all of which affect quality of care and health outcomes. Join our producers Stephanie Walker and Martha...

The landscape of medication to treat ER+, HER2 negative or low is changing rapidly as patients experience progression on CDK4/6 inhibitors and look for next steps. Now that biomarker testing is more readily available (both tissue and liquid), there are more options particularly in the PI3 kinase pathway. In this episode we will discuss biomarker testing, the PI3 kinase pathway, and an exciting new patient initiative, the PIK3CA Pathbreakers.

Today we are bringing you a special episode that we created in partnership with SHARE Cancer Support. It’s an audio version of a live webinar that was done this past February called Report back from San Antonio Breast Cancer Symposium 2023. SABCS is the world’s leading breast cancer research meeting where scientists, patient advocates, and others dedicated to working in the field of cancer gather.In this podcast, Dr. Timothy Pluard, director of the Saint Luke’s Koontz Center for Advanced Brea...